Have a personal or library account? Click to login
Weak D types 38 and 11: determination of frequencies in a Brazilian population and validation of an easy molecular assay for detection Cover

Weak D types 38 and 11: determination of frequencies in a Brazilian population and validation of an easy molecular assay for detection

Paid access
|Feb 2021

References

  1. Westhoff CM. The Rh blood group system in review: a new face for the next decade. Transfusion 2004;44:1663–73.
  2. Flegel WA. Molecular genetics and clinical applications for RH. Transfus Apher Sci 2011;44:81–91.
  3. Wagner FF, Flegel WA. The rhesus site. Transfus Med Hemother 2014;41:357–63.
  4. Westhoff CM. Rh complexities: serology and DNA genotyping. Transfusion 2007;47:17S–22S.
  5. Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999; 93:385–93.
  6. Sandler SG, Chen LN, Flegel WA. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype. Br J Haematol 2017;179:10–9.
  7. Muller TH, Wagner FF, Trockenbacher A, et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion 2001;41: 45–52.
  8. Reid ME, Halter Hipsky C, Hue-Roye K, Hoppe C. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Blood Cells Mol Dis 2014;52:195–202.
  9. Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood 2000;95:2699–708.
  10. Noizat-Pirenne F, Tournamille C. Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol 2011;18:527–35.
  11. Dezan MR, Oliveira VB, Gomes CN, et al. High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype. J Clin Lab Anal 2018;32:e22596.
  12. Costa S, Martin F, Chiba A, Langhi D Jr, Chiattone C, Bordin J. RHD alleles and D antigen density among serologically D–C+ Brazilian blood donors. Transfus Med 2014;24:60–1.
  13. Maaskant-van Wijk PA, Faas BH, de Ruijter JA, et al. Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD-specific exons. Transfusion 1998;38:1015–21.
  14. Tax MG, van der Schoot CE, van Doorn R, Douglas-Berger L, van Rhenen DJ, Maaskant-van Wijk PA. RHC and RHc genotyping in different ethnic groups. Transfusion 2002; 42:634–44.
  15. Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95:12–8.
  16. Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA. Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features. Blood 1998;91:2157–68.
  17. Chiu RW, Murphy MF, Fidler C, Zee BC, Wainscoat JS, Lo YM. Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin Chem 2001;47:667–72.
  18. Perco P, Shao CP, Mayr WR, Panzer S, Legler TJ. Testing for the D zygosity with three different methods revealed altered Rhesus boxes and a new weak D type. Transfusion 2003;43:335–9.
  19. Flegel WA, Curin-Serbec V, Delamaire M, et al. Section 1B: Rh flow cytometry. Coordinator’s report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination. Transfus Clin Biol 2002;9:33–42.
  20. Arnoni CP, Latini FR, Muniz JG, et al. A simple approach to screen rare donors in Brazil. Immunohematology 2015;31: 20–3.
  21. Costa SS, Chiba A, Cruz B, Langhi Júnior D, Bordin JO. RHD*weak D type 38: a family study. Rev Bras Hematol Hemoter 2016;38:79–81.
  22. Ansart-Pirenne H, Asso-Bonnet M, Le Pennec PY, Roussel M, Patereau C, Noizat-Pirenne F. RhD variants in Caucasians: consequences for checking clinically relevant alleles. Transfusion 2004;44:1282–6.
  23. Dogic V, Bingulac-Popovic J, Babic I, et al. Distribution of weak D types in the Croatian population. Transfus Med 2011;21:278–9.
  24. Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10.
  25. Araujo F, Rodrigues MJ, Monteiro F, et al. Weak D type 2 is the most prevalent weak D type in Portugal. Transfus Med 2006;16:63–7.
  26. Rodrigues M, Rodrigues F, Tilley L, Poole J, Chabert T, Sousa G. Several new examples of weak D type 38 in the Portuguese population [abstract]. Transfusion 2006;46(Suppl):141A–2.
  27. Ouchari M, Romdhane H, Chakroun T, et al. Weak D in the Tunisian population. Blood Transfus 2015;13:295–301.
  28. Dinardo CL, Kelly S, Dezan MR, et al. Diversity of RH and transfusion support in Brazilian sickle cell disease patients with unexplained Rh antibodies. Transfusion 2019;59: 3228–35.
DOI: https://doi.org/10.21307/immunohematology-2020-040 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 47 - 53
Published on: Feb 17, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 M.R. Dezan, V.B. Oliveira, M. Conrado, F. Luz, A. Gallucci, T.G.M. Oliveira, E.C. Sabino, V. Rocha, A. Mendrone, C.L. Dinardo, published by American National Red Cross
This work is licensed under the Creative Commons License.